Results 11 to 20 of about 7,696 (227)
Periorbital myxedema treated with intralesional hyaluronidase
American Journal of Ophthalmology Case Reports, 2020 Purpose: Periorbital myxedema is one the most challenging symptoms for patients with Graves' eye disease (GED). The treatment of this condition is complex and often unsatisfactory.
Aleksandra L Lindgren, Kathleen M Welsh
exaly +3 more sources
Journal of Epidemiology, 2017 Background: Myxedema coma is a life-threatening and emergency presentation of hypothyroidism. However, the clinical features and outcomes of this condition have been poorly defined because of its rarity.
Yosuke Ono +2 more
exaly +3 more sources
Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
Clinical Case Reports (discontinued), 2019 Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care.
Annika Janson, Mikael Finder
exaly +2 more sources
Myxedema-related cardiac tamponade diagnosed by focused cardiac ultrasound (FoCUS): a case report [PDF]
Frontiers in Cardiovascular MedicineIntroductionPericardial effusion can progress to cardiac tamponade, a life-threatening condition in which clinical findings are often nonspecific and a complete Beck's triad is frequently absent.
H. A. Nati-Castillo +6 more
doaj +2 more sources
Pretibial myxedema in Grave's disease: A case report and treatment review of the literature
Clinical Case Reports (discontinued)Key Clinical Message Pretibial myxedema is a rare skin lesion in Grave's disease, which required topical glucocorticoid administration in long‐term treatment. The patient's lesion has shrunk and become flatter than before treatment. Abstract We present a
Van Bang Nguyen, Trang Vo
exaly +2 more sources
Sequential Amiodarone-Induced Thyroid Dysfunction: From Myxedema Coma to Late-Onset Type 1 Thyrotoxicosis After Drug Withdrawal. [PDF]
Clin Case RepABSTRACT Amiodarone therapy may induce thyroid dysfunction in approximately 20% of patients, either amiodarone‐induced hypothyroidism (AIH) or thyrotoxicosis (AIT). Both situations may occur at any time during treatment or even months to years after drug withdrawal due to tissue storage with slow systemic release.
Soares DM, Ferreira L.
europepmc +2 more sources
Pretibial myxedema in a euthyroid patient: a case report
Thyroid Research, 2021 Background Pretibial myxedema also known as localized myxedema, thyroid dermopathy, or infiltrative dermopathy and rarely as localized mucinosis is an infrequent manifestation of Graves’ disease.
Rediet Ambachew +6 more
doaj +1 more source
A Rare Case of Myxedema Coma with Neuroleptic Malignant Syndrome (NMS) [PDF]
Journal of Clinical and Diagnostic Research, 2015 Myxedema coma or hypothyroid crisis is an endocrine emergency and needs ICU management. Neuroleptic malignant syndrome (NMS) is another medical emergency which needs high degree of clinical suspicion else mortality can be high. There is a paradox in co
Siddharth Dixit +2 more
doaj +1 more source
Myxedema Coma: A Rare Case of Shock Post-Pericardial Window Procedure
Clinical Medicine Insights: Cardiology, 2022 The clinical features of severe hypothyroidism vary in presentation, ranging from subclinical symptoms to multiorgan failure referred to as myxedema coma. The cornerstone treatments of myxedema coma include aggressive thyroid hormone replacement combined
Blerina Asllanaj +2 more
doaj +1 more source
Severe hypoxemia after extubation secondary to myxedema coma: a case report
Journal of International Medical Research, 2023 Myxedema coma is a rare and life-threatening endocrine emergency characterized by abnormalities in multiple organ systems. A 32-year-old woman with prolonged undiagnosed severe hypothyroidism was referred to our hospital owing to lower abdominal pain and
Jintao Sun +4 more
doaj +1 more source